Proteogenomic analysis reveals unanticipated adaptations of colorectal tumor cells to deficiencies in DNA mismatch repair.

A growing body of genomic data on human cancers poses the critical question of how genomic variations translate to cancer phenotypes. We used standardized shotgun proteomics and targeted protein quantitation platforms to analyze a panel of 10 colon cancer cell lines differing by mutations in DNA mismatch repair (MMR) genes. In addition, we performed transcriptome sequencing (RNA-seq) to enable detection of protein sequence variants from the proteomic data. Biologic replicate cultures yielded highly consistent proteomic inventories with a cumulative total of 6,513 protein groups with a protein false discovery rate of 3.17% across all cell lines. Networks of coexpressed proteins with differential expression based on MMR status revealed impact on protein folding, turnover and transport, on cellular metabolism and on DNA and RNA synthesis and repair. Analysis of variant amino acid sequences suggested higher stability of proteins affected by naturally occurring germline polymorphisms than of proteins affected by somatic protein sequence changes. The data provide evidence for multisystem adaptation to MMR deficiency with a stress response that targets misfolded proteins for degradation through the ubiquitin-dependent proteasome pathway. Enrichment analysis suggested epithelial-to-mesenchymal transition in RKO cells, as evidenced by increased mobility and invasion properties compared with SW480. The observed proteomic profiles demonstrate previously unknown consequences of altered DNA repair and provide an expanded basis for mechanistic interpretation of MMR phenotypes.

[1]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[2]  P. Massion,et al.  Methods for Peptide and Protein Quantitation by Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.

[3]  J. Nesland,et al.  Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[5]  A. Parle‐McDermott,et al.  Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization , 2002, Oncogene.

[6]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[7]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[8]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[9]  J. Casal,et al.  Novel Snail1 Target Proteins in Human Colon Cancer Identified by Proteomic Analysis , 2010, PloS one.

[10]  Seth Blackshaw,et al.  PIKE A Nuclear GTPase that Enhances PI3Kinase Activity and Is Regulated by Protein 4.1N , 2000, Cell.

[11]  L. D. Tin,et al.  Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. , 2001, The American journal of pathology.

[12]  T. Chen,et al.  DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin. , 1995, Cancer genetics and cytogenetics.

[13]  Christoph H Borchers,et al.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.

[14]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[15]  Birgit Schilling,et al.  Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. , 2010, Journal of proteome research.

[16]  Gilbert S Omenn,et al.  Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. , 2006, Journal of proteome research.

[17]  Yan P. Yuan,et al.  Frameshift peptide‐derived T‐cell epitopes: A source of novel tumor‐specific antigens , 2001, International journal of cancer.

[18]  Bing Zhang,et al.  Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression , 2010, BMC Systems Biology.

[19]  J. Haley,et al.  Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition , 2007, Molecular Cancer Therapeutics.

[20]  M. Mann,et al.  Is Proteomics the New Genomics? , 2007, Cell.

[21]  W. Pao,et al.  A Bioinformatics Workflow for Variant Peptide Detection in Shotgun Proteomics* , 2011, Molecular & Cellular Proteomics.

[22]  G. Thomas,et al.  Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers. , 2005, Human molecular genetics.

[23]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[24]  Bing Zhang,et al.  Protein identification using customized protein sequence databases derived from RNA-Seq data. , 2012, Journal of proteome research.

[25]  Jing Wang,et al.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..

[26]  F. Alt,et al.  Mre11: roles in DNA repair beyond homologous recombination , 2009, Nature Structural &Molecular Biology.

[27]  D. Tabb,et al.  MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis. , 2007, Journal of proteome research.

[28]  John R Yates,et al.  Proteomics by mass spectrometry: approaches, advances, and applications. , 2009, Annual review of biomedical engineering.

[29]  Birgit Schilling,et al.  Interlaboratory Study Characterizing a Yeast Performance Standard for Benchmarking LC-MS Platform Performance* , 2009, Molecular & Cellular Proteomics.

[30]  Matthias Mann,et al.  Proteomic Changes Resulting from Gene Copy Number Variations in Cancer Cells , 2010, PLoS genetics.

[31]  R. Coffey,et al.  Proteomic Consequences of a Single Gene Mutation in a Colorectal Cancer Model , 2011, Journal of proteome research.

[32]  M. Bertagnolli,et al.  Molecular origins of cancer: Molecular basis of colorectal cancer. , 2009, The New England journal of medicine.

[33]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[34]  Bing Zhang,et al.  Integrative Omics Analysis Reveals the Importance and Scope of Translational Repression in microRNA-mediated Regulation , 2013, Molecular & Cellular Proteomics.

[35]  B. Leggett,et al.  The impact of microsatellite instability on the molecular phenotype of colorectal tumors. , 2003, Cancer research.

[36]  Xia Han,et al.  Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity , 2004, Molecular Cancer.

[37]  Daniel C. Liebler,et al.  Comparative Shotgun Proteomics Using Spectral Count Data and Quasi-Likelihood Modeling , 2010, Journal of proteome research.

[38]  Eugene A. Kapp,et al.  Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition. , 2009, Journal of proteome research.

[39]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[40]  Hoguen Kim,et al.  Identification and Selective Degradation of Neopeptide-Containing Truncated Mutant Proteins in the Tumors with High Microsatellite Instability , 2013, Clinical Cancer Research.

[41]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.